Evidence map›Paper›PMID 39910842›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2025

Tailored Supramolecular Additives to Control the Crystallization Process and Morphology of MAPbI

Meike Kuhn, Felix A Wenzel, Christopher Greve, Klaus Kreger, Matthias Schwartzkopf, Hans-Werner Schmidt, Helen Grüninger, Eva M Herzig

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Meike KuhnDynamics and Structure Formation - Herzig Group, University of Bayreuth, Universitätsstraße 30, 95447, Bayreuth, Germany.ORCID https://orcid.org/0000-0002-3163-0254
Felix A WenzelMacromolecular Chemistry I and Bavarian Polymer Institute, University of Bayreuth, Universitätsstraße 30, 95447, Bayreuth, Germany.ORCID https://orcid.org/0000-0001-9485-0679
Christopher GreveDynamics and Structure Formation - Herzig Group, University of Bayreuth, Universitätsstraße 30, 95447, Bayreuth, Germany.ORCID https://orcid.org/0000-0001-5506-9695
Klaus KregerMacromolecular Chemistry I and Bavarian Polymer Institute, University of Bayreuth, Universitätsstraße 30, 95447, Bayreuth, Germany.ORCID https://orcid.org/0000-0003-3021-1311
Matthias SchwartzkopfDeutsches Elektronen-Synchrotron DESY, Notkestr. 85, 22607, Hamburg, Germany.ORCID https://orcid.org/0000-0002-2115-9286
Hans-Werner SchmidtMacromolecular Chemistry I and Bavarian Polymer Institute, University of Bayreuth, Universitätsstraße 30, 95447, Bayreuth, Germany.ORCID https://orcid.org/0000-0002-1761-1153
Helen GrüningerBavarian Center for Battery Technology (BayBatt) and Inorganic Chemistry, University of Bayreuth, Universitätsstraße 30, 95447, Bayreuth, Germany.ORCID https://orcid.org/0000-0002-5422-7003
Eva M HerzigDynamics and Structure Formation - Herzig Group, University of Bayreuth, Universitätsstraße 30, 95447, Bayreuth, Germany.ORCID https://orcid.org/0000-0002-0151-5562

Funding

Bayerisches Staatsministerium für Wissenschaft und KunstCRC 492723217Deutsche Forschungsgemeinschaft 510654404
6 · The paper itself

Abstract

Perovskite films feature unique optoelectronic properties, rendering them promising for electronic devices. The properties depend on the morphology on a broad range of length scales from nanometers to millimeters, influenced by a variety of factors. However, controlling the morphology is challenging. A tailored supramolecular additive, N, N'-bis(2-aminoethyl) terephthalamide is developed to control the intermediate and perovskite crystallization of methyl ammonium lead iodide (MAPbI

Indexed as

additive engineeringcrystallization controlcrystal morphologyGIWAXSperovskitessolid‐state NMR spectroscopysupramolecular additive

Identifiers

PMID39910842
PMCPMC11878263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.